News & Updates

June 16, 2026
Distalmotion Supports ASCs in Expanding GYN Service Lines with US FDA 510(k) Clearance for Additional Gynecology Indications


April 1, 2026
Distalmotion Seeks to Expand US Indications in Uro-Gynecology with Latest FDA Submission

January 13, 2026
Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System

November 18, 2025
Distalmotion Raises $150 Million to Accelerate US Expansion of the DEXTER® Robotic Surgery System and Names Chas McKhann as Executive Chairman

October 1, 2025
Distalmotion Secures Third FDA Clearance for DEXTER® with Hysterectomy Indication

August 6, 2025
Distalmotion Marks Patient Enrollment Milestones in General Surgery and Gynecology Clinical Trials for the DEXTER® Robotic Surgery System
June 24, 2025
Distalmotion Achieves Milestone in the US as AdventHealth Acquires Multiple DEXTER® Robotic Surgery Systems

May 28, 2025
Distalmotion Gains FDA 510(k) Clearance for Cholecystectomy, Further Advancing Access to Robotics in the Outpatient Setting with its DEXTER® Robotic Surgery System

April 22, 2025
Distalmotion Advances US Expansion of its DEXTER® Surgical Robot with Clinical Milestones and System Enhancements